Autonomix Medical, Inc.

For the period ended Mar 31, 2026. Filed May 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed May 27, 2026

AMIX$1.70+11.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

AUTONOMIX MEDICAL, INC.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
Date: May 27, 2026	By:	/s/ BRAD HAUSER
		Brad Hauser Chief Executive Officer, President and Director (Principal Executive Officer)
Date: May 27, 2026	By:	/s/ BRAD HAUSER
		Brad Hauser Chief Executive Officer, President and Director (Principal Executive Officer)
Date: May 27, 2026		/s/ TRENT SMITH
		Trent Smith Chief Financial Officer (Principal Financial and Accounting Officer)
Date: May 27, 2026		/s/ WALTER KLEMP
		Walter Klemp Executive Chair of the Board of Directors
Date: May 27, 2026		/s/ LORI BISSON
		Vice Chair of the Board of Directors
Date: May 27, 2026		/s/ JONATHAN FOSTER
		Jonathan Foster Director
Date: May 27, 2026		/s/ DAVID ROBINS
		David Robins Director
Date: May 27, 2026		/s/ CHRISTOPHER CAPELLI, MD
		Christopher Capelli Director

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.